Join
Live feed
·
PRReleasevia Quantisnow
Sage Therapeutics Inc. logo
Supernus Pharmaceuticals Inc. logo

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

ByQuantisnow·Wall Street's wire, on your screen.
SAGE· Sage Therapeutics Inc.SUPN· Supernus Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SAGE (Sage Therapeutics Inc.), SUPN (Supernus Pharmaceuticals Inc.) and more on Quantisnow.